Keyword

infigratinib

Description: An orally administered kinase inhibitor that targets fibroblast growth factor receptors and is used in cancer research and treatment.
Wikidata ID: wiki/Q27075200
OpenAlex ID: keywords/infigratinib
2021 · Robert Roskoski Jr. · Pharmacological Research · 225
2020 · Pablo Florenzano, Iris R. Hartley, et al. · Calcified Tissue International · 189
2021 · Anuhya Kommalapati, Sri Harsha Tella, et al. · Cancers · 178
2020 · Melanie A. Krook, Alexandria Lenyo, et al. · Molecular Cancer Therapeutics · 148
2022 · Andrew B. Lassman, Juan Manuel Sepúlveda-Sánchez, et al. · Clinical Cancer Research · 118
2021 · Connie Kang · Drugs · 110
2023 · Qibiao Wu, Haley Ellis, et al. · Clinical Cancer Research · 107
2020 · Shalini Makawita, Ghassan K Abou-Alfa, et al. · Future Oncology · 103
2019 · Chiara Casadei, Nazli Dizman, et al. · Therapeutic Advances in Medical Oncology · 101
2020 · Gehan Botrus, Puneet Raman, et al. · Expert Opinion on Investigational Drugs · 54
2022 · Ravi Savarirayan, Josep Maria De Bergua, et al. · Therapeutic Advances in Musculoskeletal Disease · 53
2022 · N. Normanno, E. Martinelli, et al. · ESMO Open · 50
2024 · Ravi Savarirayan, Josep Maria De Bergua, et al. · New England Journal of Medicine · 42
2021 · Zhiwei Wang, Yinghao Guo, et al. · Cancer Cell International · 39
2021 · Gabriella Aitcheson, Amit Mahipal, et al. · Expert Opinion on Investigational Drugs · 37
2022 · Taotao Li, Gaoling Zhang, et al. · Frontiers in Oncology · 32
Works count: 321
Citation count: 3,980
Year
Topic
Type